Igor Popa - Concepedia

Author

Igor Popa

Palacký University Olomouc ORCID

Also Known As

I Popa, I. A. Popa, I. Popa, Igor Popa, Ionuţ POPA, Popa, I., Popa, Igor

115

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Palacký University Olomouc Czech Academy of Sciences, Institute of Experimental Botany Institute of Molecular and Translational Medicine Regional Centre of Advanced Technologies and Materials

About

Igor Popa is an author at Palacký University Olomouc specializing in pharmacology, natural sciences, and inorganic chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	15	21	702
2	Biochemistry	14	16	624
3	Medicine	12	12	518
4	Engineering	10	11	266
5	Biomolecular Engineering	8	8	232

Igor Popa

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Preparation and biological activity of 6-benzylaminopurine derivatives in plants and human cancer cells Karel Doležal, Igor Popa, Vladimı́r Kryštof, Bioorganic & Medicinal Chemistry Biological ActivityChemoprevention StrategyBiochemistryMedicineNatural Sciences	2005	128
Preparation, biological activity and endogenous occurrence of N6-benzyladenosines Karel Doležal, Igor Popa, Eva Hauserová, Bioorganic & Medicinal Chemistry Biological ActivityBiochemistryNatural SciencesOrganic ChemistryHeterocycle Chemistry	2007	110
The purine derivative PI‐55 blocks cytokinin action via receptor inhibition Lukáš Spíchal, Tomáš Werner, Igor Popa, FEBS Journal EngineeringCellular PharmacologyArabidopsis SeedsPharmacotherapyCellular Physiology	2008	77
Synthesis, characterization and biological activity of ring-substituted 6-benzylamino-9-tetrahydropyran-2-yl and 9-tetrahydrofuran-2-ylpurine derivatives Lucie Szüčová, Lukáš Spíchal, Karel Doležal, Bioorganic & Medicinal Chemistry Biological ActivityDerivativesBiochemistry9-Tetrahydrofuran-2-ylpurine DerivativesNatural Sciences	2009	66
Cytokinin receptor antagonists derived from 6-benzylaminopurine Jaroslav Nisler, Marek Zatloukal, Igor Popa, Phytochemistry Cytokinin Receptor AntagonistsMedicineMechanism Of ActionPharmacological AgentPharmacotherapy	2010	61
Dinuclear copper(II) complexes containing 6-(benzylamino)purines as bridging ligands: Synthesis, characterization, and in vitro and in vivo antioxidant activities Pavel Štarha, Zdeněk Trávnı́ček, Radovan Herchel, Journal of Inorganic Biochemistry Inorganic ChemistryVivo Antioxidant ActivitiesCoordination ComplexDinuclear CopperMolecular Complex	2008	60
Novel platinum(II) and palladium(II) complexes with cyclin-dependent kinase inhibitors: Synthesis, characterization and antitumour activity Lucie Szüčová, Zdeněk Trávnı́ček, Marek Zatloukal, Bioorganic & Medicinal Chemistry Inorganic ChemistryCyclin-dependent Kinase InhibitorsNovel PlatinumMedicineCoordination Complex	2005	57
How to modify 7-azaindole to form cytotoxic Pt(II) complexes: Highly in vitro anticancer effective cisplatin derivatives involving halogeno-substituted 7-azaindole Pavel Štarha, Zdeněk Trávnı́ček, Alexandr Popa, Journal of Inorganic Biochemistry Medicinal ChemistryCoordination ComplexCytotoxic PtMolecular ComplexAnti-cancer Agent	2012	49
Synthesis, characterization and in vitro cytotoxicity of the first palladium(II) oxalato complexes involving adenine-based ligands Pavel Štarha, Zdeněk Trávnı́ček, Igor Popa Journal of Inorganic Biochemistry Inorganic ChemistryOxalato ComplexesAdenine-based LigandsBiochemistryNatural Sciences	2009	40
Cytotoxic conjugates of betulinic acid and substituted triazoles prepared by Huisgen Cycloaddition from 30-azidoderivatives Veronika Šidová, Pavel Zoufalý, J. Pokorný, PLoS ONE Huisgen CycloadditionChemoprevention StrategyHeterocycle ChemistryHuisgen 1,3-CycloadditionPharmaceutical Chemistry	2017	39

Page 1